Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0505BY08 Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2784.39 C124H217N5O63
LMSP0505BO07 Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2229.18 C102H180N4O48
LMSP0505BO06 Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2259.22 C104H186N4O48
LMSP0505BV05 Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2231.19 C102H182N4O48
LMSP0505DY08 Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2647.37 C120H210N6O57
LMSP0505BM07 GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 1832.05 C88H157N3O36
LMSP0505EI03 Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2362.21 C106H187N5O52
LMSP0505EI01 Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2306.15 C102H179N5O52
LMSP0505CC08 GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2444.29 C112H197N5O52
LMSP0505CF08 Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0505BE04 Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 2041.11 C94H168N4O43
LMSP0505AH03 Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 1794 C84H151N3O37
LMSP0505CF05 Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] 1704.01 C82H149N3O33
LMSP0506AR01 Cytolipin R(d18:1/16:0) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1226.75 C60H110N2O23
LMSP0506AR02 Cytolipin R(d18:1/18:0) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1254.78 C62H114N2O23
LMSP0506AR03 Cytolipin R(d18:1/20:0) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1282.81 C64H118N2O23
LMSP0506AR04 Cytolipin R(d18:1/22:0) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1310.84 C66H122N2O23
LMSP0506AR05 Cytolipin R(d18:1/24:0) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1338.88 C68H126N2O23
LMSP0506AR07 Cytolipin R(d18:1/24:1(15Z)) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1336.86 C68H124N2O23
LMSP0506AR06 Cytolipin R(d18:1/26:0) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1366.91 C70H130N2O23
LMSP0506AR08 Cytolipin R(d18:1/26:1(17Z)) GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1364.89 C70H128N2O23
LMSP0506AD01 Forssman-like iGb4(d18:1/16:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1429.83 C68H123N3O28
LMSP0506AD02 Forssman-like iGb4(d18:1/18:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1457.86 C70H127N3O28
LMSP0506AD03 Forssman-like iGb4(d18:1/20:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1485.89 C72H131N3O28
LMSP0506AD04 Forssman-like iGb4(d18:1/22:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1513.92 C74H135N3O28
LMSP0506AD05 Forssman-like iGb4(d18:1/24:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1541.95 C76H139N3O28
LMSP0506AD07 Forssman-like iGb4(d18:1/24:1(15Z)) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1539.94 C76H137N3O28
LMSP0506AD06 Forssman-like iGb4(d18:1/26:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1569.99 C78H143N3O28
LMSP0506AD08 Forssman-like iGb4(d18:1/26:1(17Z)) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1567.97 C78H141N3O28
LMSP0506AQ01 Isoglobotriglycosylceramide(d18:1/16:0) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1023.67 C52H97NO18
LMSP0506AQ02 Isoglobotriglycosylceramide(d18:1/18:0) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1051.7 C54H101NO18
LMSP0506AQ03 Isoglobotriglycosylceramide(d18:1/20:0) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1079.73 C56H105NO18
LMSP0506AQ04 Isoglobotriglycosylceramide(d18:1/22:0) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1107.76 C58H109NO18
LMSP0506AQ05 Isoglobotriglycosylceramide(d18:1/24:0) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1135.8 C60H113NO18
LMSP0506AQ07 Isoglobotriglycosylceramide(d18:1/24:1(15Z)) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1133.78 C60H111NO18
LMSP0506AQ06 Isoglobotriglycosylceramide(d18:1/26:0) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1163.83 C62H117NO18
LMSP0506AQ08 Isoglobotriglycosylceramide(d18:1/26:1(17Z)) Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1161.81 C62H115NO18
LMSP0506AS01 iGb5(d18:1/16:0) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1388.8 C66H120N2O28
LMSP0506AS02 iGb5(d18:1/18:0) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1416.83 C68H124N2O28
LMSP0506AS03 iGb5(d18:1/20:0) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1444.87 C70H128N2O28
LMSP0506AS04 iGb5(d18:1/22:0) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1472.9 C72H132N2O28
LMSP0506AS05 iGb5(d18:1/24:0) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1500.93 C74H136N2O28
LMSP0506AS07 iGb5(d18:1/24:1(15Z)) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1498.91 C74H134N2O28
LMSP0506AS06 iGb5(d18:1/26:0) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1528.96 C76H140N2O28
LMSP0506AS08 iGb5(d18:1/26:1(17Z)) Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1526.94 C76H138N2O28
LMSP0506BB05 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1646.99 C80H146N2O32
LMSP0506AA04 Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1253.82 C64H119NO22
LMSP0506AJ04 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1879.06 C88H158N4O38
LMSP0506BA01 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1550.86 C72H130N2O33
LMSP0506BJ01 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1737.94 C80H143N3O37